WUXI APPTEC (603259.SH): First buyback of 0.3793 million shares.

On April 18, Gelonghui reported that WUXI APPTEC (603259.SH) announced the implementation of a share repurchase of its A-shares for the first time through centralized bidding on April 18, 2025. The number of repurchased shares is 379,300 shares, accounting for 0.0131% of the company's total share capital as of the date of this announcement. The maximum repurchase price is RMB 52.95 per share, the minimum repurchase price is RMB 52.52 per share, and the total amount of funds used is RMB 20,008,733.00 (excluding transaction fees).

Gelonghui FinanceApr 18 17:13

UBS Group AG has reduced its shareholding in WUXI APPTEC (02359) by approximately 2.5769 million shares, at a price of about 46.87 Hong Kong dollars per share.

After the Shareholding reduction, the latest number of shares held is approximately 26.0237 million shares, with a shareholding ratio of 6.72%.

Zhitong FinanceApr 17 19:32

Morgan Stanley has reduced its shareholding in WUXI APPTEC (02359) by approximately 0.5347 million shares, with each share priced at about 51.33 Hong Kong dollars.

After the Shareholding reduction, the latest number of shares held is approximately 30.4429 million shares, with a shareholding ratio of 7.86%.

Zhitong FinanceApr 17 19:31

Express News | HKEX information shows that UBS Group's Hold Positions in WUXI APPTEC (02359.HK) listed in Hong Kong decreased from 7.39% on April 11 to 6.72%.

BreakingsApr 17 17:18

Sinolink: The risk of customs duties is low when going abroad with BD. Bullish on the internationalization process of Innovative Drugs.

Investors are advised to focus on pharmaceutical companies that have previously gone overseas through business development (BD), or those with mature technology platforms that can continue to produce Innovative Drugs pipelines in the future and possess BD potential.

Zhitong FinanceApr 17 09:17

Has the SSE Health Care theme Index risen again? This year, the public fund performance has shuffled, with the highest return of the health care theme Fund exceeding 44%, and Inflow of capital has accelerated.

As of April 16, two SSE Health Care theme Index Funds have entered the top 10 performances of actively managed equity funds this year; Since April, multiple Hwabao WP CSI Medical Service ETFs have seen significant net subscriptions, with the total amount of fund shares for these medical ETFs reaching a new high; Fund managers believe that the pharmaceutical sector is not just undervalued in parts, but is comprehensively undervalued, and the nature of Innovative Drugs has changed.

cls.cnApr 17 08:31